Report for de Roo G

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (2)

Title : Preclinical Profile of the HER2-Targeting ADC SYD983\/SYD985: Introduction of a New Duocarmycin-Based Linker-Drug Platform - Dokter_2014_Mol.Cancer.Ther_13_2618
Author(s) : Dokter W , Ubink R , van der Lee M , van der Vleuten M , van Achterberg T , Jacobs D , Loosveld E , van den Dobbelsteen D , Egging D , Mattaar E , Groothuis P , Beusker P , Coumans R , Elgersma R , Menge W , Joosten J , Spijker H , Huijbregts T , de Groot V , Eppink M , de Roo G , Verheijden G , Timmers M
Ref : Mol Cancer Ther , 13 :2618 , 2014
Abstract : Dokter_2014_Mol.Cancer.Ther_13_2618
ESTHER : Dokter_2014_Mol.Cancer.Ther_13_2618
PubMedSearch : Dokter_2014_Mol.Cancer.Ther_13_2618
PubMedID: 25189543

Title : Influence of growth stage on activities of polyhydroxyalkanoate (PHA) polymerase and PHA depolymerase in Pseudomonas putida U - Ren_2010_BMC.Microbiol_10_254
Author(s) : Ren Q , de Roo G , Witholt B , Zinn M , Thony-Meyer L
Ref : BMC Microbiol , 10 :254 , 2010
Abstract : Ren_2010_BMC.Microbiol_10_254
ESTHER : Ren_2010_BMC.Microbiol_10_254
PubMedSearch : Ren_2010_BMC.Microbiol_10_254
PubMedID: 20937103